-
1.9.ALPHA.-CHLORO-6.ALPHA.-FLUORO-17.ALPHA.-HYDROXY-16-METHYL-17-BETA-METHOXYCARBONYL-ANDROST-1,4-DIENES ESTERIFIED IN POSITION 17.ALPHA. BY A CYCLIC ACYL GROUP 有权
标题翻译: 9.ALPHA.氯6.ALPHA.氟17.ALPHA.羟基-16-甲基-17-β-甲氧羰基 - 雄甾-1,4-二烯IN THE 17.ALPHA。 逐环状酯基酯化公开(公告)号:EP1299409B1
公开(公告)日:2005-04-06
申请号:EP01962783.5
申请日:2001-06-26
申请人: Novartis AG , Novartis Pharma GmbH
发明人: CUENOUD, Bernard , BEATTIE, David , KELLER, Thomas, Hugo , PILGRIM, Gaynor, Elizabeth , SANDHAM, David, Andrew , WATSON, Simon, James
CPC分类号: C07J41/0038 , C07J3/005 , C07J17/00 , C07J33/002 , C07J41/0094 , C07J43/003 , C07J71/0015
摘要: Compounds of formula (I), where R is a monovalent cyclic organic group having from 3 to 15 atoms in the ring system, useful as pharmaceuticals.
-
2.GLUCOCORTICOID 16ALPHA,17.ALPHA.-ISOXAZOLIDINES AS ANTI-INFLAMMATORY AGENTS 审中-公开
标题翻译: 糖皮质激素16alpha,17α-乙烯异恶唑烷用作抗炎活性成分公开(公告)号:EP1809648A2
公开(公告)日:2007-07-25
申请号:EP05763604.5
申请日:2005-07-13
申请人: Novartis AG , NOVARTIS-PHARMA GMBH
IPC分类号: C07J1/00
CPC分类号: C07J1/00
摘要: Compounds of formula (I) in free or salt form, wherein R1 and R2 have the meanings as indicated in the specification, are useful for treating inflammatory conditions, particularly inflammatory or obstructive airways disease. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
-
3.9.ALPHA.-CHLORO-6.ALPHA.-FLUORO-17.ALPHA.-HYDROXY-16-METHYL-17-BETA-METHOXYCARBONYL-ANDROST-1,4-DIENES ESTERIFIED IN POSITION 17.ALPHA. BY A CYCLIC ACYL GROUP 有权
标题翻译: 9.ALPHA.氯6.ALPHA.氟17.ALPHA.羟基-16-甲基-17-β-甲氧羰基 - 雄甾-1,4-二烯IN THE 17.ALPHA。 逐环状酯基酯化公开(公告)号:EP1299409A2
公开(公告)日:2003-04-09
申请号:EP01962783.5
申请日:2001-06-26
申请人: Novartis AG , Novartis Pharma GmbH
发明人: CUENOUD, Bernard , BEATTIE, David , KELLER, Thomas, Hugo , PILGRIM, Gaynor, Elizabeth , SANDHAM, David, Andrew , WATSON, Simon, James
CPC分类号: C07J41/0038 , C07J3/005 , C07J17/00 , C07J33/002 , C07J41/0094 , C07J43/003 , C07J71/0015
摘要: Compounds of formula (I), where R is a monovalent cyclic organic group having from 3 to 15 atoms in the ring system, useful as pharmaceuticals.
-
-